Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
For AI to make a truly damaging dent in COVID-19’s armor, developers need to better connect big-data analytics with regularly refreshed input from frontline healthcare workers.
In a pilot study of 16 patients, the system’s recommendations were deemed safe by expert endocrinologists at a clip of more than 99% over the course of four weeks.
Machine learning is playing a key role in predicting all major forms of drug cardiotoxicity, potentially helping reduce late-stage clinical trial failures.
As an academic AI expert, Pascale Fung, PhD, dove into the scientific research when she was diagnosed with breast cancer in 2015. The time investment rewarded her with a depth of understanding that has helped shape her life as a cancer survivor.
Researchers have found that spiking neural networks become unstable after unbroken periods of unsupervised self-training. Moreover, these “artificial brains” seem to restabilize after they’re given the equivalent of a good night’s rest.
AI is stepping in to help speed up the diagnosis of COVID-19 and expedite how much time healthcare professionals spend determining COVID-19 pneumonia and non-COVID-19 cases.
The World Health Organization announced it will resume a clinical trial evaluating the efficacy of hydroxychloroquine for COVID-19 patients after the organization halted it following studies showing higher risks to patients taking the drug.
